Can plant protein and exercise keep seniors strong?
NCT ID NCT07155824
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a blend of plant and whey protein, combined with a 12-week exercise program, affects protein digestion and muscle health in 15 inactive older adults. Researchers measured how the body uses amino acids from meals and checked muscle tissue markers. The goal was to understand the body's response, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- whey and plant protein blend with physical activity
- What this could lead to
- If successful, this could help design better nutrition and exercise plans to maintain muscle health in older adults.
- What could go wrong
- This is a very small, early-stage study (15 participants) focused on understanding mechanisms, not proving a treatment works. Results may not apply to all older adults.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
15 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * BMI 22-30 kg/m² * Inactive (\<150 minutes of moderate to vigorous physical activity per week and no regular resistance training), * Covered by a social security system * Agrees to undergo the study interventions (undirect calorimetry, functional tests, physical activity program) Exclusion Criteria: * Hamilton HAD scale with a score \> 9 * Subject with a pathology or treatment (diabetic on insulin, corticosteroids \> 8 days, neuroleptics, anticoagulant, antiplatelet) judged by the investigator as incompatible with the study * Subject with unstabilized thyroid dysfunction for at least 3 months * Subject with unstabilized hypertension for at least 3 months * Subject with a medical and/or surgical history judged by the investigator as incompatible with the trial * More than 21 alcoholic drinks per week * Heavy smoker (\>10 cigarettes/day) * Currently participating in another intervention study * Absence of informed consent * Inability to participate in physical activity * Allergy(ies) or refusal to consume one of the foods tested as part of the the study * Allergy to local anesthetics * Declared glaucoma * Prostate hypertrophy * Refusal to register in the national file of volunteers who participate in research involving human beings * Subject in a period of exclusion from a previous study or having received a total amount of compensation greater than 6,000 euros over the 12 months preceding the start of the trial (after verification in the File of Volunteers for Research involving Human Beings) * Patients under guardianship, curatorship, deprived of liberty or legal protection * Subject with claustrophobia
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Eldery people are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.